Emmanuelle Boishardy – General Manager, GSK Czech Republic
Emmanuelle Boishardy joined GSK in France 20 years ago. In 2017, she embarked on her first assignment as General Manager – in the Czech affiliate. She recounts how she adapted…
Zentiva, a generic platform of Sanofi, is the third largest and fastest growing generics company in Europe. Its history dates back to the 15th century and it has a splendid reputation in the market for its generic products.
Zentiva has four key production plants in Central and Eastern Europe, enabling it to manufacture and distribute products across all its markets quickly and efficiently. Zentiva maintains the highest product quality and security standards across their manufacturing and supply lines. Their modern state-of-the-art facilities employ almost 3,000 people and produce an annual output of 440 million units, making Zentiva one of the largest producers of pharmaceuticals, by volume, in Europe.
Zentiva provides affordable and reliable medicines to patients and healthcare providers throughout Europe.
Zentiva is a member of the Sanofi Group.
Contact
Zentiva Group, as
U Kabelovny 130.
102 37 Prague 10
Czech Republic
T: +420 267 241 111
F: +420 272 702 402
Emmanuelle Boishardy joined GSK in France 20 years ago. In 2017, she embarked on her first assignment as General Manager – in the Czech affiliate. She recounts how she adapted…
With a footprint of over 20 years in the Czech Republic, Gedeon Richter’s affiliate here is a key pillar to the company’s success in the Central Eastern European region. Corina…
Josef Kredba, country manager Czech Republic at G.L. Pharma, an Austrian pharmaceutical company, explains how the company has returned to growth in the challenging Czech generics market and shares his…
Jan Škrha, president of the Czech Diabetes Society (ČDS), provides insight into the most crucial advances in the quality care of Diabetes, which relies on the indispensable cooperation between specialists…
Here we highlight five of the most important women working in healthcare and the life sciences in Central & Eastern Europe (CEE) today. From regulators to pharma affiliate heads with…
Tomáš Votruba of the Association of Full-Line Wholesalers (AVEL), which gathers the three major players of the pharmaceutical distribution market in the Czech Republic, gives an overview of the current…
Tomáš Dolezal, president of the International Society for Pharmacoeconomics and Outcomes (ISPOR) Czech Regional Chapter and director of the Institute of Health Economics and Technology Assessment (iHETA), gives an overview…
Sandoz’s Jiří Hanzlík, country head for the Czech Republic, evaluates the Czech affiliate’s role in contributing to the success of Sandoz globally as well as its position in the country.…
Jakub Dvořáček, CEO of the Czech Association of Innovative Pharmaceutical Industry (AIFP), describes the thorough review of the reimbursement scheme the association has worked on alongside other key stakeholders in…
Bioinova’s CEO and managing director MUDr Peter Bauer PhD introduces the biotech company’s shift from a university spin-off to a privately held entity. Whilst describing the powerful properties of stem…
Štěpán Svačina, Chairman of the Czech Medical Association (CzMA), gives insights into the challenges that the Czech Republic faces in bringing change to the life sciences infrastructure. Whilst pointing out…
The Czech Republic’s Minister of Health, Adam Vojtěch, is the youngest in the country’s history and has set out an ambitious reform programme to improve the state of the Czech…
See our Cookie Privacy Policy Here
